Skip to Content

TEVA 5004 (Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 5 mg / 25 mg / 40 mg)

Pill with imprint TEVA 5004 is Yellow, Capsule-shape and has been identified as Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil 5 mg / 25 mg / 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Amlodipine/hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Amlodipine/hydrochlorothiazide/olmesartan 5 mg / 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5004

Amlodipine besylate, hydrochlorothiazide and olmesartan medoxomil 5 mg / 25 mg / 40 mg TEVA 5004

Amlodipine Besylate, Hydrochlorothiazide and Olmesartan Medoxomil

Imprint:
TEVA 5004
Strength:
5 mg / 25 mg / 40 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC):
00093-5004

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide